Biochemical modulation of cytarabine triphosphate by clofarabine.
about
Treating refractory leukemias in childhood, role of clofarabineClofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialA randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndromeClofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.Clofarabine in leukemia.The role of clofarabine in acute myeloid leukemia.Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.Clofarabine: emerging role in leukemias.Clofarabine for the treatment of adult acute myeloid leukemia.A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group.Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.Clofarabine for the treatment of acute lymphoblastic leukemia.Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemiaJust getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression.Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.Targeting of polo-like kinases and their cross talk with Aurora kinases--possible therapeutic strategies in human acute myeloid leukemia?Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.High-dose cytarabine (HD araC) in the treatment of leukemias: a review.Clofarabine in the treatment of myelodysplastic syndromes.Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments.Isolation and characterization of a murine P388 leukemia line resistant to clofarabine.Guanosine acts intracellularly to initiate apoptosis in NB4 cells: A role for nucleoside transport.Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemiaClofarabine combinations as acute myeloid leukemia salvage therapy.Use of clofarabine for acute childhood leukemia.Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M
P2860
Q24647279-4CD1722C-69F2-4A29-88DA-B29398128660Q33401218-5B290331-2E5F-413B-B79D-D7A61720E15FQ33843955-828CC494-E306-4481-BA0F-1273074000D2Q33949752-E61B81E1-8799-4AE6-B159-6D86E5ACF0E8Q33968321-F25BE776-0E83-4D24-A95D-78B5D4B6236AQ34021009-6E7AAD00-2A98-4CC7-9F21-7603AA28E72AQ34150263-3CF79072-FEAE-46A2-9342-912ABBFCF079Q34298181-77078CF7-F652-4B2E-92E5-BD1D9039E0B8Q34544604-31CF3283-3C9E-4169-8CE8-DA2474F7370BQ34679387-0CBFD3E4-C188-4F38-8200-E72E83A28188Q35000135-7A456C75-5627-47F2-A73D-4FF6180DA862Q35009273-50E76777-703D-4C22-810E-3570A42F3E7AQ35399015-29791912-756D-41B9-9C78-923A31D35109Q35546759-F7C1D27C-0A34-4A16-9062-9F0E28F857B9Q35740894-CD53B770-B1B2-4764-9AA8-726A4017D6E1Q35990683-76410CB6-4155-41DD-A71D-3CC627B61D40Q36161733-E90D15DE-3B40-4BF2-935C-BC5C7D4F79FAQ36326258-EB0FDDAE-A54F-41A3-A5BF-16817507B469Q36731404-30CB5B5B-6B42-48F7-820B-A878269BA846Q36806921-2FCDBFCF-E85F-442A-B949-97B81CF24C6DQ36931187-211395F5-94B5-4F92-BFA0-A2A369809069Q37347515-42D022C9-8F8C-453F-9A00-F744635CA009Q37994256-2707F04B-CC21-4BAF-8A81-C75403254AD0Q38097334-335B7383-A39C-407B-B4CA-86B52FC16925Q38105942-5BDC7CC9-1BC8-4DF6-A8AA-A483CCDA871EQ38177310-210C43E7-2D65-4952-96F5-C19C73E9EF46Q38226402-CA150DEE-E495-43FA-9A87-A016640C1AC7Q38569175-DC28174E-29A6-48FC-8D2D-96A7E32C36BFQ39446984-C911E975-E5A7-492F-B3C6-AB5CBCF3EF6DQ40084915-FDE585C9-9F1D-4622-9027-619CC71A407FQ41961502-9844D79D-5D15-433A-8D70-7C81D9B8028CQ42048738-E211D962-D406-4966-B629-514AB1178856Q42737704-22BC9113-BAC2-42A2-A381-D311F87C700FQ48215705-5FAB8CDD-805C-4120-93B8-C3D58B69A2D7Q51098678-9EB27B9E-7680-4FA4-880B-DEDC58B59637
P2860
Biochemical modulation of cytarabine triphosphate by clofarabine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biochemical modulation of cytarabine triphosphate by clofarabine.
@en
type
label
Biochemical modulation of cytarabine triphosphate by clofarabine.
@en
prefLabel
Biochemical modulation of cytarabine triphosphate by clofarabine.
@en
P2093
P1476
Biochemical modulation of cytarabine triphosphate by clofarabine.
@en
P2093
Billie Nowak
Mary Ayres
Todd Cooper
Varsha Gandhi
P2888
P304
P356
10.1007/S00280-004-0906-Y
P577
2004-10-16T00:00:00Z
P6179
1001013549